What is your approach to MRD testing in the frontline treatment of multiple myeloma?
How frequently and what type of testing/sample are you performing MRD assessment?
Does your approach differ between transplant-eligible and transplant-ineligible patients?
Answer from: Medical Oncologist at Academic Institution
Outside of clinical trials, I am not ordering MRD testing for patients in the newly diagnosed setting, regardless of transplant eligibility. While there are substantial data showing that MRD status correlates with survival outcomes (e.g., Munshi et al., Blood Adv 2020), there is a dearth of informat...
Comments
Medical Oncologist at Medical University of South Carolina Could not agree more - for some reason (big pharma...
Could not agree more - for some reason (big pharma...